{
  "title": [
    "Stada Arzneimittel AG"
  ],
  "Type": [
    "Aktiengesellschaft"
  ],
  "Traded as": [
    "FWB: SAZ"
  ],
  "Industry": [
    "Pharmaceuticals"
  ],
  "Founded": [
    "Dresden, 1895"
  ],
  "Headquarters": [
    "Bad Vilbel, Germany"
  ],
  "Key people": [
    "Peter Goldschmidt CEO",
    "Günter von Au (Chairman of the supervisory board)"
  ],
  "Products": [
    "Generic and over-the-counter drugs"
  ],
  "Revenue": [
    "€2.33 billion  (2018)"
  ],
  "Operating income": [
    "€378.1 million  (2018)"
  ],
  "Net income": [
    "€306.9 million  (2018)"
  ],
  "Total assets": [
    "€3.335 billion  (end 2014)"
  ],
  "Total equity": [
    "€903.3 million  (end 2014)"
  ],
  "Number of employees": [
    "10,416  (FTE, average 2018)"
  ],
  "Website": [
    "www.stada.com"
  ]
}